-
Mashup Score: 0FDA approves Abbott's spinal cord stimulation system for diabetic peripheral neuropathy - 1 year(s) ago
Abbott announced today that the FDA approved its spinal cord stimulation system for treating painful diabetic peripheral neuropathy (DPN).
Source: MassDeviceCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Chronic Pain - 1 year(s) ago
Chronic pain is more common than most people can imagine, affecting people of all ages and stages in life.
Source: www.bostonscientific.comCategories: Latest Headlines, Pain ManagementTweet
-
Mashup Score: 0Leading experts in Neuromodulation (SCS & DBS) - 1 year(s) ago
Hear from our leading experts in Spinal Cord Stimulation and Deep Brain Stimulation about the potential to improve your patients’ quality of life and explore the importance of a well-informed referral network.
Source: www.bostonscientific.comCategories: Latest Headlines, Pain ManagementTweet-
Explore the benefits of #SpinalCordStimulation (SCS) for #ChronicPain with Dr @GeorgiosMatis. Neurologists play a crucial role in initiating a timely treatment journey with #SCS. Let's start the conversation and help our patients find pain relief: https://t.co/6rKy1IVPz4 #BSCEMEA https://t.co/arOdX2JJoE
-
-
Mashup Score: 0Chronic Pain - 1 year(s) ago
Chronic pain is more common than most people can imagine, affecting people of all ages and stages in life.
Source: www.bostonscientific.comCategories: Latest Headlines, Pain ManagementTweet
-
Mashup Score: 0Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
The cost effectiveness, risks, and benefits of spinal cord stimulation for chronic pain were assessed in a retrospective comparative effectiveness study.
Source: Clinical Pain AdvisorCategories: Healthcare Professionals, Latest HeadlinesTweet-
Study Does Not Support #SpinalCord Stimulation Over Usual Care for #ChronicPain https://t.co/c0x478DICB #SCS How SAFE Is Real-world Use of #SpinalCordStimulation Therapy for Chronic Pain? 1.https://t.co/VsyHThM8iN 2.https://t.co/3FUhRfYXT8 #NeuropathicPain #DoNoHarm #MedTwitter https://t.co/wsMYEZaqqc
-
-
Mashup Score: 0Abbott Launches the World's Smallest Implantable, Rechargeable Spinal Cord Stimulation System for Chronic Pain - 1 year(s) ago
/PRNewswire/ — Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) approval of the company’s Eterna™ spinal cord stimulation (SCS)…
Source: www.prnewswire.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
Retrospective study finds no reduction in opioid use vs conventional medical management
Source: www.medpagetoday.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0WaveWriter Alpha™ SCS - 1 year(s) ago
Learn about Alpha, the newest generation of WaveWriter spinal cord stimulator chronic pain management device by Boston Scientific.
Source: www.bostonscientific.comCategories: Latest Headlines, Pain ManagementTweet
-
Mashup Score: 0
Medtronic today reported second-quarter financial results that beat Wall Street expectations on earnings but missed on revenue.
Source: MassDeviceCategories: Healthcare Professionals, Latest HeadlinesTweet
#FDA approves Abbott’s spinal cord stimulation #SCS system for diabetic #peripheralneuropathy | #diabetes https://t.co/fiqg1V3HoH